Sign in
4

Changes in Ownership

UNITED THERAPEUTICS Corp Filed Acc 0001237334-26-000005

Director sold 1,300 shares at $604.64 ($786,032)

  • Director acquired 1,300 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

CAUSEY CHRISTOPHER · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-03-30 Exercise or conversion : show line 1 in the form 10b5-1 +1,300 $119.76 $155,688 5,490 D
2026-03-30 Sale : show line 2 in the form 10b5-1 −1,300 $604.64 $786,032 4,190 D
Open-market sales · 1,300 sh · avg $604.64 · $786,032

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-03-30 Exercise or conversion : show line 3 in the form 10b5-1 Stock Option −1,300 5,000 D
Loading xslF345X06/primarydocument.xml…